3 companies
argenx
Market Cap: €42.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€677.00
7D
4.6%
1Y
28.4%
Atenor
Market Cap: €100.2m
Operates as a real estate development company in Belgium, Hungary, Poland, the Netherlands, France, Portugal, Romania, Luxembourg, Germany, and the United Kingdom.
ATEB
€1.65
7D
-4.6%
1Y
-41.7%
Recticel
Market Cap: €564.3m
An insulation company, provides thermal and thermo-acoustic solutions in Belgium, France, the Netherlands, Germany, Slovenia, other European Union countries, the United Kingdom, the United States, and internationally.
RECT
€10.00
7D
4.0%
1Y
-1.4%